Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.

FDA Insight

U.S. Food and Drug Administration

Compounded Drugs

JAN 5, 202110 MIN
FDA Insight

Compounded Drugs

JAN 5, 202110 MIN

Description

Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.